Is the coprescription of β blockers and β2 agonists justified in COPD?
- Dr A Singh, Department of Pulmonary Medicine, Christian Medical College and Hospital, Ludhiana 141010, India; drsinghakashdeep{at}gmail.com
Dransfield and colleagues1 advocate the use of β blockers even in patients admitted with acute exacerbations of chronic obstructive pulmonary disease (COPD), but certain points need further discussion.
Their retrospective analysis highlights the discordance in practice that exists between cardiologist and pulmonologist. Indeed, the former is keen to commence β blockers in patients with a wide range of cardiovascular diseases …









